METRO MAYAGUEZ — History
CCN 400123 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$51M
Latest Revenue (FY2022)
+7.9%
Revenue CAGR (3yr)
-2.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $43M | $50M | $51M | +0.8% | +7.9% |
| Operating Expenses | $45M | $49M | $52M | +5.1% | +7.2% |
| Operating Margin | -4.3% | 1.3% | -2.9% | -315.5% | +0.0% |
| Net Income | $-2M | $1M | $-1M | -317.2% | +0.0% |
| Licensed Beds | 117 | 123 | 122 | -0.8% | +2.1% |
| Total Patient Days | 26,337 | 28,316 | 31,159 | +10.0% | +8.8% |
| Medicare Day % | 9% | 7% | 7% | -0.9% | -16.3% |
| Medicaid Day % | 22% | 25% | 26% | +4.1% | +9.5% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +16.4% ($43M → $51M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.9%
This Hospital
+7.6%
State Avg
Latest Margin
-2.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $54M | -2.2% |
| FY2024 (proj) | $58M | -1.5% |
| FY2025 (proj) | $61M | -0.8% |